BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32497088)

  • 1. Echocardiographic screening to determine progression of latent rheumatic heart disease in endemic areas: A systematic review and meta-analysis.
    Gutman SJ; Shemesh E; Marwick TH; Taylor AJ
    PLoS One; 2020; 15(6):e0234196. PubMed ID: 32497088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up echocardiographic changes in children and youth aged <25 years with latent rheumatic heart disease: A systematic review and meta-analysis of global data.
    Francia CJ; Fraser JF; Justo R; Cassimatis J; Manoy S; Johnston LM
    Int J Cardiol; 2024 May; 403():131911. PubMed ID: 38428505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.
    Beaton A; Aliku T; Dewyer A; Jacobs M; Jiang J; Longenecker CT; Lubega S; McCarter R; Mirabel M; Mirembe G; Namuyonga J; Okello E; Scheel A; Tenywa E; Sable C; Lwabi P
    Circulation; 2017 Dec; 136(23):2233-2244. PubMed ID: 28972003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. School and Community Screening Shows Malawi, Africa, to Have a High Prevalence of Latent Rheumatic Heart Disease.
    Sims Sanyahumbi A; Sable CA; Beaton A; Chimalizeni Y; Guffey D; Hosseinipour M; Karlsten M; Kazembe PN; Kennedy N; Minard CG; Penny DJ
    Congenit Heart Dis; 2016 Dec; 11(6):615-621. PubMed ID: 27029239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of asymptomatic rheumatic heart disease among refugee/migrant children and youths in Italy.
    Condemi F; Rossi G; Lupiz M; Pagano A; Zamatto F; Marini S; Romeo F; De Maio G
    Pediatr Rheumatol Online J; 2019 Apr; 17(1):12. PubMed ID: 30940181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study.
    Nascimento BR; Sable C; Nunes MCP; Diamantino AC; Oliveira KKB; Oliveira CM; Meira ZMA; Castilho SRT; Santos JPA; Rabelo LMM; Lauriano KCA; Carmo GAL; Tompsett A; Ribeiro ALP; Beaton AZ;
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29444774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies.
    Noubiap JJ; Agbor VN; Bigna JJ; Kaze AD; Nyaga UF; Mayosi BM
    Sci Rep; 2019 Nov; 9(1):17022. PubMed ID: 31745178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiography screening to detect rheumatic heart disease: A cohort study of schoolchildren in French Pacific Islands.
    Mirabel M; Fauchier T; Bacquelin R; Tafflet M; Germain A; Robillard C; Rouchon B; Marijon E; Jouven X
    Int J Cardiol; 2015 Jun; 188():89-95. PubMed ID: 25889336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study.
    Zühlke L; Engel ME; Lemmer CE; van de Wall M; Nkepu S; Meiring A; Bestawros M; Mayosi BM
    BMC Cardiovasc Disord; 2016 Feb; 16():46. PubMed ID: 26892774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year evolution of latent rheumatic heart disease in Malawi.
    Sanyahumbi A; Beaton A; Guffey D; Hosseinipour MC; Karlsten M; Minard CG; Penny DJ; Sable CA; Kazembe PN
    Congenit Heart Dis; 2019 Jul; 14(4):614-618. PubMed ID: 30706669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection.
    Beaton A; Okello E; Aliku T; Lubega S; Lwabi P; Mondo C; McCarter R; Sable C
    Pediatr Cardiol; 2014 Oct; 35(7):1259-67. PubMed ID: 24827080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening.
    Francis JR; Fairhurst H; Hardefeldt H; Brown S; Ryan C; Brown K; Smith G; Baartz R; Horton A; Whalley G; Marangou J; Kaethner A; Draper AD; James CL; Mitchell AG; Yan J; Ralph A; Remenyi B
    Med J Aust; 2020 Aug; 213(3):118-123. PubMed ID: 32632952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease?
    Rémond M; Atkinson D; White A; Brown A; Carapetis J; Remenyi B; Roberts K; Maguire G
    Int J Cardiol; 2015 Nov; 198():117-22. PubMed ID: 26163902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatic heart disease in Timor-Leste school students: an echocardiography-based prevalence study.
    Davis K; Remenyi B; Draper AD; Dos Santos J; Bayley N; Paratz E; Reeves B; Appelbe A; Cochrane A; Johnson TD; Korte LM; Do Rosario IM; Da Silva Almeida IT; Roberts KV; Carapetis JR; Francis JR
    Med J Aust; 2018 Apr; 208(7):303-307. PubMed ID: 29642817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
    Nascimento BR; Nunes MCP; da Silva JLP; Steer A; Engelman D; Okello E; Rwebembera J; Zuhlke L; Mirabel M; Nakitto M; Sarnacki R; Ribeiro ALP; Sable CA; Beaton AZ;
    Int J Cardiol; 2024 Mar; 399():131662. PubMed ID: 38141728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children.
    Roberts K; Maguire G; Brown A; Atkinson D; Reményi B; Wheaton G; Kelly A; Kumar RK; Su JY; Carapetis JR
    Circulation; 2014 May; 129(19):1953-61. PubMed ID: 24622384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified Echocardiography Screening Criteria for Diagnosing and Predicting Progression of Latent Rheumatic Heart Disease.
    Nunes MCP; Sable C; Nascimento BR; Lima EM; da Silva JLP; Diamantino AC; Oliveira KKB; Okello E; Aliku T; Lwabi P; Colosimo EA; Ribeiro ALP; Beaton AZ
    Circ Cardiovasc Imaging; 2019 Feb; 12(2):e007928. PubMed ID: 30704283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular Regurgitation Using Portable Echocardiography in a Healthy Student Population: Implications for Rheumatic Heart Disease Screening.
    Webb RH; Gentles TL; Stirling JW; Lee M; O'Donnell C; Wilson NJ
    J Am Soc Echocardiogr; 2015 Aug; 28(8):981-8. PubMed ID: 25959548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.